admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

GH Research Reports First Quarter 2023 Financial Results and Provides Business...

Brain scanning technology to be used for clinical psychedelics trials in...

Sunstone Therapies to present data on the long-term efficacy of psilocybin...

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces...

COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

MIND CURE CLOSES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT

Optimi Health Granted Natural Health Product Site Licence By Health Canada

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces...

PT409 – Pathology, the DSM, and the Ontological Shock of Psychedelic...

Terran Biosciences announces publication of PCT patent application covering novel non-hallucinogenic...

1...676869...218 Page 68 of 218

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin